Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328–57.
Article
PubMed
Google Scholar
Wong VW, Wong GL, Choi PC, Chan AW, Li MA, Chan HY, et al. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut. 2010;59(7):969–74.
Article
PubMed
Google Scholar
Li J, Zou BY, Yeo YH, Feng Y, Xie X, Lee DH, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2019;4(5):389–98.
Article
PubMed
Google Scholar
Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34(3):274–85.
Article
CAS
PubMed
Google Scholar
Lin YX, Liu X, Cen C, Li X, Liu JM, Ming ZY, et al. Comparison and development of advanced machine learning tools to predict nonalcoholic fatty liver disease: an extended study. Hepatobiliary Pancreat Dis Int. 2021;20(5):409–15.
Article
Google Scholar
Meynial-Denis D. Glutamine metabolism in advanced age. Nutr Rev. 2016;74(4):225–36.
Article
PubMed
PubMed Central
Google Scholar
Pontzer H, Yamada Y, Sagayama H, Ainslie PN, Andersen LF, Arab L, et al. Daily energy expenditure through the human life course. Science. 2021;373(655):808–12.
Article
CAS
PubMed
PubMed Central
Google Scholar
Amarapurkar DN, Hashimoto E, Lesmana LA, Sollano JD, Chen PJ, Goh KL, et al. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? J Gastroenterol Hepatol. 2007;22(6):788–93.
Article
PubMed
Google Scholar
Estes C, Anstee QM, Arias-Loste MT, Bantel H, Bellentani S, Caballeria J, et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030. J Hepatol. 2018;69(4):896–904.
Article
PubMed
Google Scholar
Shen L, Fan JG, Shao Y, Zeng MD, Wang JR, Luo GH, et al. Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey. World J Gastroenterol. 2003;9(5):1106–10.
Article
PubMed
PubMed Central
Google Scholar
Wu Y, Zheng Q, Zou B, Yeo YH, Li X, Li J, et al. The epidemiology of NAFLD in Mainland China with analysis by adjusted gross regional domestic product: a meta-analysis. Hepatol Int. 2020;14(2):259–69.
Article
PubMed
Google Scholar
Yan H, Lu XF, Luo JY, Zhou XY. Epidemiological analysis of alcoholic and non-alcoholic fatty liver in Shanxi and Gansu province. Chin J Gastroenterol Hepatol. 2007;16(4):347–53.
Google Scholar
Shi XD, Wei Q, He SM, Tao YC, Sun J, Niu JQ. Epidemiology and analysis on risk factors of non-infectious chronic diseases in adults in northeast China. J Jilin Univ (Medicine Edition). 2011;37(2):379–84.
CAS
Google Scholar
Shi L, Liu ZW, Li Y, Gong C, Zhang H, Song LJ, et al. The prevalence of nonalcoholic fatty liver disease and its association with lifestyle/dietary habits among university faculty and staff in Chengdu. Biomed Environ Sci. 2012;25(4):383–91.
PubMed
Google Scholar
Shah AG, Lydecker A, Murray K, Tetri BN, Contos MJ, Sanyal AJ, et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009;7(10):1104–12.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lin ZH, Xin YN, Dong QJ, Wang Q, Jiang XJ, Zhan SH, et al. Performance of the aspartate aminotransferase–to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology. 2011;53(3):726–36.
Article
PubMed
Google Scholar
National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association, Fatty Liver Expert Committee, Chinese Medical Doctor Association. Guidelines of prevention and treatment for nonalcoholic fatty liver disease: a 2018 update. Zhonghua Gan Zang Bing Za Zhi. 2018;26(3):195–203.
Prati D, Taioli E, Zanella A, Torre ED, Butelli S, Vecchio ED, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. 2002;137(1):1–10.
Article
CAS
PubMed
Google Scholar
Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202–9.
Article
PubMed
Google Scholar
Westeneng HW, Veenhuijzen K, Spek RA, Peters S, Visser AE, Rheenen W, et al. Associations between lifestyle and amyotrophic lateral sclerosis stratified by C9orf72 genotype: a longitudinal, population-based, case-control study. Lancet Neurol. 2021;20(5):373–84.
Article
CAS
PubMed
Google Scholar
Marchesini G, Mazzotti A. NAFLD incidence and remission: only a matter of weight gain and weight loss? J Hepatol. 2015;62(1):15–7.
Article
PubMed
Google Scholar
Wu W, Feng A, Ma W, et al. Worldwide long-term trends in the incidence of nonalcoholic fatty liver disease during 1990–2019: a joinpoint and age-period-cohort analysis. Front Cardiovasc Med. 2022;9: 891963.
Article
PubMed
PubMed Central
Google Scholar
Aneni EC, Saeed GJ, Bittencourt MS, et al. Cardiometabolic disorders, inflammation and the incidence of non-alcoholic fatty liver disease: a longitudinal study comparing lean and non-lean individuals. PLoS ONE. 2022;17(4): e0266505.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhou J, Feng Zhou F, Wang W, et al. Epidemiological features of NAFLD from 1999 to 2018 in China. Hepatology. 2020;71(5):1851–64.
Article
PubMed
Google Scholar
Polyzos SA, Kountouras J, Mantzoros CS. Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics. Metabolism. 2019;92:82–97.
Article
CAS
PubMed
Google Scholar
Zhou M, Zhu NB, Yu CQ, Du HD, Lv J, Guo Y, et al. Analysis on adulthood weight change in adults in China. Chin J Epidemiol. 2019;40(5):510–4.
CAS
Google Scholar
Wang J, Ma L, Chen S, Xu L, Miao M, Yu C, et al. Risk for the development of non-alcoholic fatty liver disease: a prospective study. J Gastroenterol Hepatol. 2018;33(8):1518–23.
Article
CAS
PubMed
Google Scholar
Yu XY, Zhao Y, Song X, Song Z. The association between body mass index and non-alcoholic fatty liver disease. J Zhejiang Univ (Medical Sciences). 2014;43:546–52.
CAS
Google Scholar
Zhao YC, Zhao GJ, Chen Z, She Z, Cai J, Li H. Nonalcoholic fatty liver disease: an emerging driver of hypertension. Hypertension. 2020;75(2):275–84.
Article
CAS
PubMed
Google Scholar
Sung KC, Wild SH, Byrne CD. Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension. J Hepatol. 2014;60(5):1040–5.
Article
PubMed
Google Scholar
Ciardullo S, Grassi G, Mancia G, Perseghin G. Nonalcoholic fatty liver disease and risk of incident hypertension: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2022;34(4):365–71.
Article
CAS
PubMed
Google Scholar
Wang B, Li M, Zhao Z, Wang S, Lu J, Chen Y, et al. Glycemic measures and development and resolution of nonalcoholic fatty liver disease in nondiabetic individuals. J Clin Endocrinol Metab. 2020;105(5): dgaa112.
Article
PubMed
Google Scholar
Wei F, Li J, Chen C, Zhang K, Cao L, Wang X, et al. Higher serum uric acid level predicts non-alcoholic fatty liver disease: a 4-year prospective cohort study. Front Endocrinol (Lausanne). 2020;11:179.
Article
PubMed
Google Scholar
Yamada G, Hagiwara Y, Kimura T, Takeuchi Y, Oba K, Masuda K, et al. Impact of body weight gain on the incidence of nonalcoholic fatty liver disease in nonobese Japanese individuals. Am J Gastroenterol. 2021;116(4):733–40.
Article
PubMed
Google Scholar
Rim JH, Youk T, Gee HY, Cho J, Yoo J. Dynamic chronological changes in serum triglycerides are associated with the time point for non-alcoholic fatty liver disease development in the nationwide korean population cohort. Front Med (Lausanne). 2021;8: 637241.
Article
PubMed
Google Scholar
Ciardullo S, Ballabeni C, Trevisan R, Perseghin G. Liver fibrosis assessed by transient elastography is independently associated with albuminuria in the general United States population. Dig Liver Dis. 2021;53(7):866–72.
Article
CAS
PubMed
Google Scholar
Eslam M, Sarin SK, Wong VW, Fan J, Kawaguchi T, Ahn SH, et al. The Asian Pacific association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatol Int. 2020;14:889–919.
Article
PubMed
Google Scholar